Merger Update: Dechra / Elanco

The CMA has decided, on the information currently available to it, not to refer the following merger to a Phase 2 investigation under the provisions of the Enterprise Act 2002:

Title of Merger case: Anticipated acquisition by Dechra Pharmaceuticals Plc of the Osurnia Business of Elanco Animal Health Incorporated

The text of this decision will be placed on the Competition and Markets Authority's website at https://www.gov.uk/cma-cases/dechra-pharmaceuticals-plc-osurnia-business-of-elanco-animal-health-incorporated-merger-inquiry as soon as is reasonably practicable.

In the event of media enquiries please email Press@cma.gov.uk 

For Publicity:

The full title of the Merger Case: Anticipated acquisition by Dechra Pharmaceuticals Plc of the Osurnia Business of Elanco Animal Health Incorporated

The SIC code

The affected market: Pharmaceuticals

The merger reference code ME/6878/20